ACTIVE

APOTHEEK GRIETJE PAEME

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result-11,6 k €+69,8 %over 1 year
Gross margin190,6 k €+19,0 %over 1 year
Equity227,2 k €-4,8 %over 1 year
Workforce2,0 ETP0,0 %over 1 year

Identity

Source · BCE/KBO

APOTHEEK GRIETJE PAEME is a Private limited company incorporated in 2010. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Bruxelles. It employs on average 2,0 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0829.837.275
Incorporation
23/09/2010
Legal form
Private limited company
Registered office
Avenue de l'Arbre Ballon 115 box 10
1020 Bruxelles · BruxellesSee on map
Contributed capital
40 000,00 €
Latest accounts
31/12/2025
Average workforce
2,0 ETP
Joint committees (1)
  • 313
Signals
Solid equityGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 15 filings

Trend over 15 financial years

20252024202320222021
Income statement
Gross margin190,6 k €160,1 k €161,1 k €243,9 k €108,6 k €
EBITDA43,3 k €17,8 k €63 k €159,1 k €26,9 k €
Operating result-3,9 k €-30,6 k €7,8 k €103,3 k €-32,3 k €
Net result-11,6 k €-38,3 k €2,5 k €94 k €-41,2 k €
Balance sheet
Equity227,2 k €238,8 k €277,1 k €274,7 k €210,7 k €
Total assets630,6 k €664,9 k €755,5 k €835,8 k €850,7 k €
Cash53,8 k €13,4 k €10,9 k €43,1 k €38,7 k €
Debts401,6 k €422,8 k €475,6 k €558,4 k €637,5 k €
Other
Workforce2,0 ETP2,0 ETP2,0 ETP1,2 ETP1,0 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 0 € and 100 k€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 3 ended

Active mandates

PAEME pharma

Director · 0812.307.989

Represented by Grietje Paeme

Active

Ended mandates

PAEME pharma

Manager · since 04 octobre 2010 · 0812.307.989

Represented by Grietje Paeme

Ended
PAEME pharma

Manager · since 04 octobre 2010 · 0812.307.989

Represented by Grietje Paeme

Ended
PAEME pharma

Manager · 0812.307.989

Represented by Grietje Paeme

Ended

Other companies at this address

Avenue de l'Arbre Ballon 115 1020 Bruxelles
CompanyCBE no.
PAEME pharma● Active
0812.307.989

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date04/07/202631/08/202528/06/202407/07/202324/08/202228/06/2021
General meeting29/05/202630/05/202531/05/202416/06/202327/05/202228/05/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 15 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202529/05/202604/07/2026DutchPDF
Abridged model31/12/202430/05/202531/08/2025DutchPDF
Abridged model31/12/202331/05/202428/06/2024DutchPDF
Abridged model31/12/202216/06/202307/07/2023DutchPDF
Abridged model31/12/202127/05/202224/08/2022DutchPDF
Abridged model31/12/202028/05/202128/06/2021DutchPDF
Abridged model31/12/201917/08/202010/09/2020DutchPDF
Abridged model31/12/201831/05/201928/06/2019DutchPDF
Abridged model31/12/201715/06/201813/07/2018DutchPDF
Abridged model31/12/201626/05/201723/06/2017DutchPDF
Abridged model31/12/201517/06/201602/08/2016DutchPDF
Abridged model31/12/201419/06/201514/08/2015DutchPDF
Abridged model31/12/201320/06/201411/08/2014DutchPDF
Abridged model31/12/201231/05/201310/06/2013DutchPDF
Abridged model31/12/201125/05/201209/07/2012DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 0 € and 100 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 3 ended

Active mandates

PAEME pharma

Director · 0812.307.989

Represented by Grietje Paeme

Active

Ended mandates

PAEME pharma

Manager · since 04 octobre 2010 · 0812.307.989

Represented by Grietje Paeme

Ended
PAEME pharma

Manager · since 04 octobre 2010 · 0812.307.989

Represented by Grietje Paeme

Ended
PAEME pharma

Manager · 0812.307.989

Represented by Grietje Paeme

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates28/12/2023
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - WIJZIGING RECHTSVORM - DIVERSEN - ONTSLAGEN - BENOEMINGEN
    PDF
  • Other13/10/2010
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025-11,6 k €↑
  2. 2024
    Annual accounts 2024-38,3 k €↓
  3. 2023
    Annual accounts 20232,5 k €↓
  4. 2022
    Annual accounts 202294 k €↑
  5. 2021
    Annual accounts 2021-41,2 k €↓
  6. 2020
    Annual accounts 2020-2,5 k €↓
  7. 2019
    Annual accounts 201972,3 k €↓
  8. 2018
    Annual accounts 2018126,7 k €↑
  9. 2017
    Annual accounts 201774,5 k €↓
  10. 2016
    Annual accounts 2016101,9 k €↑
  11. 2015
    Annual accounts 201564,6 k €↑
  12. 2014
    Annual accounts 201421,2 k €↓
  13. 2013
    Annual accounts 201341,7 k €↓
  14. 2012
    Annual accounts 201260,2 k €↑
  15. 2011
    Annual accounts 201128,8 k €
  16. 23/09/2010
    IncorporationPrivate limited company